Twin Peaks Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Twin Peaks Wealth Advisors's VRTX Position: Q2 2026 in Review
Twin Peaks Wealth Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q2 2026, closing a stake of 280 shares — an estimated $125K sold.
Twin Peaks Wealth Advisors first reported a position in VRTX in Q2 2025 and held it in 2 quarters. The position peaked at $125K in Q1 2026. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Twin Peaks Wealth Advisors reported no remaining Vertex Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Twin Peaks Wealth Advisors sold 280 Vertex Pharmaceuticals shares in Q2 2026, an estimated $125K.
- Twin Peaks Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q2 2025 and held it in 2 quarters.
- Twin Peaks Wealth Advisors's Vertex Pharmaceuticals position peaked at $125K in Q1 2026.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.